Acadia Pharma (ACAD) Resumes Trading at 5:45 PM ET
March 29, 2016 5:43 PM
Acadia Pharma ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Next Articles
Aegis Capital Affirms Acadia Pharma (ACAD) at 'Buy' Following Positive FDA Panel Review; Sees Nuplazid Approval SoonMarch 30, 2016 10:44 AM
Needham & Company Remains Bullish on Acadia Pharma (ACAD) Following Positive FDA Vote on Nuplazid March 30, 2016 6:49 AM
Acadia Pharma (ACAD) Surges 25% as Trading ResumesMarch 29, 2016 5:52 PM
Acadia Pharma (ACAD) Announces Favorable FDA Panel Vote on NUPLAZID for the Treatment of Psychosis Associated with Parkinson's DiseaseMarch 29, 2016 5:14 PM
FDA Advisory Committee Votes 12 to 2 That Benefits of ACADIA Pharmaceuticals’ NUPLAZID™ (Pimavanserin) for the Treatment of Psychosis Associated with Parkinson’s Disease Outweigh the RisksMarch 29, 2016 5:13 PM
Acadia Pharma (ACAD) wins FDA panel backing for Nuplazid - BloombergMarch 29, 2016 3:37 PM
Acadia Pharma (ACAD) adequately characterized the safety profile of NUPLAZID - FDA PanelMarch 29, 2016 3:19 PM
Acadia Pharma's (ACAD) NUPLAZID Seen Effective in Parkinson's - FDA PanelMarch 29, 2016 2:55 PM
Acadia Pharma (ACAD) Said Facing 'Tough' Nuplazid Efficacy Questions from FDA PanelMarch 29, 2016 10:14 AM
Acadia Pharma (ACAD) Halted Ahead of FDA PDAC Review of NUPLAZID March 29, 2016 7:05 AM
ACADIA Pharmaceuticals Stock Trading Halted TodayMarch 29, 2016 7:05 AM
Acadia Pharma (ACAD) trading halted with news pendingMarch 29, 2016 7:00 AM
